Browse
Submit Data
Databases
API
Help

Dataset Information

23 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

To Compare Artificial Intelligence Software Aided Adenoma Detection in Screening Colonoscopies Versus Standard Colonoscopy Without Artificial Intelligence Software Assistance in Participants Between 45 and 75 Years of Age

ABSTRACT: The aim of this study is to assess the efficacy of Ultivision Artificial Intelligence (AI) Software in detecting adenomas in screening colonoscopy procedures. The safety of Ultivision AI Software will also be assessed. A subset of the subjects will enter a roll-in period for clinical trial safety assessment. The remainder of subjects who are eligible will enter the detection phase which comprises a screening colonoscopy procedure. In the detection phase, subjects will be randomized to a screening colonoscopy with Ultivision AI Software enhancement or without AI Software enhancement. The study will measure the mean adenomas per colonoscopy procedure, as defined by the protocol, detected while receiving either treatment option.

DISEASE(S): Colorectal Adenocarcinoma,Colorectal Adenoma,Colorectal Ssa,Colorectal Cancer,Adenoma,Colorectal Polyp

PROVIDER: 2324463 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Artificial Intelligence-powered Drug Discovery against CTLA-4 in Cancer

Project description:Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) plays a pivotal role in preventing autoimmunity and fostering anticancer immunity by interacting with B7 proteins CD80 and CD86. CTLA-4 is the first immune checkpoint targeted with a monoclonal antibody inhibitor. Checkpoint inhibitors have generated durable responses in many cancer patients, representing a revolutionary milestone in cancer immunotherapy. However, therapeutic efficacy is limited to a small portion of patients, and immune-related adverse events are noteworthy, especially for monoclonal antibodies directed against CTLA-4. Previously, small molecules have been developed to impair the CTLA-4: CD80 interaction; however, they directly targeted CD80 and not CTLA-4. In this study, we performed artificial intelligence (AI)-powered virtual screening of approximately ten million compounds to target CTLA-4. We validated primary hits with biochemical, biophysical, immunological, and experimental animal assays. We then optimized lead compounds and obtained inhibitors with an inhibitory concentration of 1 micromole in disrupting the interaction between CTLA-4 and CD80. Unlike ipilimumab, these small molecules did not degrade CTLA-4. Several compounds inhibited tumor development prophylactically and therapeutically in syngeneic and CTLA-4-humanized mice. This project supports an AI-based framework in designing small molecules targeting immune checkpoints for cancer therapy.

2024-02-15 | GSE228560 | GEO

Veridation research of colonoscopy using artificial intelligence

Project description:Interventions: colonoscopy with/without AI (computer-aided detection) colonoscopy without AI (computer-aided detection) Primary outcome(s): Adenoma detection rate in total colonoscopy Study Design: Parallel Randomized

| 2739307 | ecrin-mdr-crc

Interest of Artificial Intelligence in Cancer Screening Colonoscopy

Project description:Artificial Intelligence (AI) to predict the histology of polyps per colonoscopy, offers a promising solution to reduce variation in colonoscopy performance. This new and innovative non-invasive technology will improve the quality of screening colonoscopies, and reduce the costs of colorectal cancer screening. The aim of the study is to performed a cross-sectional, multi-center study evaluating the diagnostic performance of the CAD EYE automatic characterization system for the histology of colonic polyps in colorectal cancer screening colonoscopy.

| 2380194 | ecrin-mdr-crc

Effect of an Artificial Intelligence Computer-Aided Detection System on Adenoma Detection: A Multicenter Randomized Controlled Trial

Project description:Interventions: SC-AI group:standard colonoscopy is performed first, followed by AI-assisted colonoscopy;AI-SC group:AI-assisted colonoscopy is performed first, followed by standard colonoscopy Primary outcome(s): adenoma miss rate Study Design: Cross-over

| 80559 | ecrin-mdr-crc

Does Artificial Intelligence Improve Polyp Detection at Colonoscopy?

Project description:Interventions: Usual standard of care from the endoscopist doctor, with addition of Endo-AID (Olympus Corporation) AI module to be on during withdrawal phase of colonoscopy. -Usual standard of care: single colonoscopy, which may take between 3-30 minutes. During withdrawal phase, which may take between 6 and 60 minutes, the AI module will be activated. It is not known if use of this module will increase the withdrawal time (compared to standard of care, without it). -The nurses will advise the doctor of the randomisation (AI or standard of care), and turn on the AI device once withdrawal has commenced. -The AI will analyse the video output from the scope to automatically detect suspected polyps in real-time during withdrawal. Polyps would then be further analysed and resected as per usual standard of care. Primary outcome(s): ADR (Adenoma Detection Rate) - proportion of patients with at least one histologically proven adenoma or carcinoma. Histology will be assessed using standard procedure in the laboratory. This data will be gathered from colonoscopy reports and lab reports of patients[At time of colonoscopy] Study Design: Purpose: Diagnosis; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Efficacy

| 2737810 | ecrin-mdr-crc

Accuracy of Real Time Characterization in Artificial Intelligence-assisted Colonoscopy

Project description:The goal of this substudy is to investigate the accuracy of a computer-aided polyp characterization (CADx) system. The main question[s] it aims to answer are: • How high is the specificity of the AI system when characterizing colorectal polyps Participants will receive a standard colonoscopy, assisted by the artificial intelligence (AI) assisted system GI Genius. Researchers will compare the AI system´s characterization with the histopathology to see how accurate the system is.

| 10350 | ecrin-mdr-crc

A high-resolution, nanopore-based artificial intelligence assay for DNA replication stress in human cancer cells

Project description:Human cancer cell lines were pulsed with thymidine analogues EdU and BrdU, sequenced on the Oxford Nanopore platform, and analysed with our DNAscent software to measure DNA replication stress.

2024-04-01 | GSE216926 | GEO

Comparison of Flat Colorectal Lesion Detection by Artificial Intelligence-assisted Colonoscopy Versus Endoscopists

Project description:The development of artificial intelligence (AI) systems in the field of colorectal endoscopy is currently booming, colorectal cancer being, by its frequency and severity, a real public health problem. In terms of image analysis, AI is indeed able to perform many tasks simultaneously (lesion detection, classification, and segmentation) and to combine them. Lesion detection is thus the starting point of the whole chain to choose at the end the most appropriate treatment for the patient. Large-scale studies have demonstrated the superiority of artificial intelligence-assisted detection over the usual detection by gastroenterologists, mainly for the detection of sub-centimeter polyps. However, the investigators have shown that a recent computer-aided detection system (CADe) such as the ENDO-AID software in combination with the EVIS X1 video column (Olympus, Tokyo, Japan) may present difficulties in the detection of flat lesions such as sessile serrated lesions (SSLs) and non-granular laterally spreading tumors (LST-NGs). This represents a major challenge because in addition to their shape being difficult to identify for the human eye in practice and where AI assistance would be of great value, these rare lesions are associated with advanced histology. In addition, the investigators recently described the case of a worrisome false negative of AI-assisted colonoscopy, which failed to detect a flat adenocarcinoma in the transverse colon. Therefore, it is important to measure the false negative rate of AI detection based on the macroscopic shape of the lesion. Comparing this rate to the human endoscopist’s false negatives would improve the performance of AI for this specific lesion subtype in the future.

| 66296 | ecrin-mdr-crc

Artificial Intelligence in Colonoscopy for Cancer Prevention -a Randomized Health Service Implementation Project-

Project description:Interventions: Real-time use of AI for polyp detection during colonoscopy Colonoscopy without use of AI Primary outcome(s): -Short-term primary endpoints 1. Adenoma detection rate (ADR) 2. Advanced adenoma detection rate (A-ADR) -Long-term primary endpoints 1. Incidence of colorectal cancers after 10-years follow-up 2. Mortality from colorectal cancers after 10-years follow-up Study Design: Parallel Randomized

| 2660772 | ecrin-mdr-crc

Prospective evaluation of a new artificial intelligence system for the classification of colonic polyps.

Project description:Interventions: Group 1: colonoscopy with AI System Primary outcome(s): The rate of correctly classified polyps detected by the AI system (accuracy). The polyp classification is documented during the colonoscopy using the case report form(CRF). Later the result is compared with histology(gold standard). Study Design: Allocation: N/A: single arm study; Masking: Open (masking not used); Control: uncontrolled; Assignment: single; Study design purpose: prevention

| 2733414 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data